Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis.

Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis.

Publication date: May 08, 2025

Aim of this study was to compare the diagnostic yield of induced sputum (IS) and bronchoalveolar lavage (BAL) in patients with suspected pulmonary tuberculosis (PTB) and negative sputum smears. We enrolled 215 patients who underwent both IS and BAL after two negative spontaneous sputum samples. PTB was confirmed by culture or molecular test in 26 patients (12. 1%). IS detected 10 cases (38. 5%) of all PTB, while BAL detected 22 cases (84. 6%) of all PTB. IS had a sensitivity of 38. 46% and a specificity of 100%, while BAL had a sensitivity of 84. 62% and a specificity of 100%. BAL had a higher diagnostic yield than IS and was useful for ruling out alternative diagnoses. According to our experience FBS execution is mandatory in case of strong TB suspicion and sputum smear negative patients, especially in a low TB prevalence country. Moreover, it consents testing microorganism sensitivity and assessing possible alternative diagnosis with similar clinical presentation. The choice of the best diagnostic method may depend on the clinical context and the availability of resources.

Open Access PDF

Concepts Keywords
Bronchoalveolar Adult
Execution Aged
Microorganism Bronchoalveolar Lavage
Tuberculosis Bronchoalveolar Lavage Fluid
Female
Humans
Male
Middle Aged
Mycobacterium tuberculosis
Sensitivity and Specificity
Sputum
Tuberculosis, Pulmonary
Young Adult

Semantics

Type Source Name
disease MESH pulmonary tuberculosis
drug DRUGBANK Dimercaprol
disease IDO country
pathway REACTOME Reproduction
disease MESH Infectious Diseases
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Ethanol
disease IDO immunosuppression
disease MESH sweating
disease MESH weight loss
disease MESH chest pain
drug DRUGBANK Apomorphine
disease IDO drug susceptibility
disease MESH bronchospasm
drug DRUGBANK Water
drug DRUGBANK Medical air
disease IDO symptom
drug DRUGBANK Gold
disease IDO immunodeficiency
disease MESH Alcoholism
pathway KEGG Alcoholism
disease MESH Chronic renal failure
disease MESH latent infection
disease MESH Dyspnea
disease MESH abnormalities
disease MESH adenopathy
disease IDO production
drug DRUGBANK Ademetionine
drug DRUGBANK Trestolone

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *